BEACON CRC: A randomized, 3-Arm, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BINI) versus choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer Meeting Abstract
| Authors: | Desai, J.; Kopetz, S.; Grothey, A.; Van Cutsem, E.; Yaeger, R.; Wasan, H.; Yoshino, T.; Ciardello, F.; Gollerkeri, A.; Maharry, K.; Loupakis, F.; Hong, Y. S.; Steeghs, N.; Guren, T. K.; Arkenau, H. T.; Alfonso, P. G.; Price, T.; Strickland, A.; Tebbutt, N.; Karapetis, C.; Chantrill, L.; Murphy, F.; Sandor, V.; Christy-Bittel, J.; Anderson, L.; Tabernero, J. |
| Abstract Title: | BEACON CRC: A randomized, 3-Arm, phase 3 study of encorafenib (ENCO) and cetuximab (CETUX) with or without binimetinib (BINI) versus choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer |
| Meeting Title: | 46th Annual Scientific Meeting of the Clinical Oncology Society of Australia (COSA) |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 15 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2019 Nov 12-14 |
| Meeting Location: | Adelaide, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-11-01 |
| Start Page: | 99 |
| Language: | English |
| ACCESSION: | WOS:000493438400120 |
| PROVIDER: | wos |
| PUBMED: | 31674106 |
| DOI: | 10.1111/ajco.13262 |
| Notes: | Meeting Abstract: 123 -- Source: Wos |
